CCOC(=O)c1c(-n2c(C)cc(/C=C3/C(=O)NC(=O)N(CC)C3=O)c2C)sc2c1CCCC2
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?